Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.

Rainer Johannes KlementIlinca PoppDavid KaulFelix EhretAnca L GrosuBülent PolatReinhart A SweeneyVictor Lewitzki

Published in: Journal of neuro-oncology (2021)

Since HFRT with temozolomide was not associated with worse OS, we assume HFRT to be a potential option for patients wishing to shorten their treatment time.

Keyphrases

newly diagnosed
ejection fraction
squamous cell carcinoma
risk assessment
cross sectional
locally advanced
combination therapy
climate change
smoking cessation